Kiran Mazumdar-Shaw, Executive Chairperson at Biocon in a company filing to BSE said, "We welcome ADQ as our investment partner as we pursue our shared goal of expanding access to high quality affordable biopharmaceuticals to patients across the globe."from Stocks-Markets-Economic Times
Read The Rest:economictimes...
